Rochester (1)

Autoimmune Pancreatitis (1)

IgG4-related Disease (1)

IgG4-related Sclerosing Cholangitis (1)

Immunoglobulin G Subclass 4 Related Disease (1)

Retroperitoneal Fibrosis (1)

Completed (1)

phase 1 (1)

Mayo Clinic (1)

Celgene Corporation (1)

lenalidomide (1)

rituximab (1)

drug (1)

Other (1)

Interventional (1)

immunoglobulin g subclass 4 related disease

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Jul 3, 2019